Augustin, M., J. Wegtowska, M. Lebwohl, C. Paul, V. Piguet, H. Sofen, A. Blauvelt, L. Peterson, and E. al. “Durability of Response in Patients With Chronic Plaque Psoriasis Treated With Certolizumab Pegol over 48 Weeks: Pooled Results from Ongoing Phase 3, Multicenter, Randomized, Placebo-Controlled Studies (CIMPASI-1, CIMPASI-2 and CIMPACT)”. SKIN The Journal of Cutaneous Medicine, vol. 2, Dec. 2018, p. S87, doi:10.25251/skin.2.supp.88.